Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

AUTLAUTL
Showing 8 of 29 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in AUTOLUS THERAPEUTICS LTD

CITADEL ADVISORS LLC holds 695,890 shares of AUTL (AUTOLUS THERAPEUTICS LTD), worth $1.1M as of 2026-Q2. The position was increased (+51.5% shares). AUTL represents 0.0% of CITADEL ADVISORS LLC's portfolio.

Current Value

$1.1M

Current Shares

695,890

Total Value Change

+$13,505

Total Shares Change

+392,882

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
695,890
+51.5%
$1.1M0.0%$1.60
35
2026-Q1
Decreased
459,404
-60.4%
$633,9780.0%$1.62
0
2025-Q4
Decreased
1.2M
-80.8%
$2.3M0.0%$1.97
0
2025-Q3
Increased
6M
+501.8%
$9.9M0.0%$1.59
45
2025-Q2
Increased
1M
+431.7%
$2.3M0.0%$2.31
42
2025-Q1
Decreased
188,908
-41.7%
$292,8070.0%$1.66
0
2024-Q4
Increased
324,002
+6.9%
$761,4050.0%$2.21
26
2024-Q3
Decreased
303,008
-42.4%
$1.1M0.0%$3.63
0

Other major holders of AUTL: Blackstone Inc., WELLINGTON MANAGEMENT GROUP LLP, Avoro Capital Advisors LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used